Navigation Links
Data evaluates rehospitalization and cost burden of AFib/atrial flutter
Date:5/4/2011

Two studies to be presented this week address the often-overlooked costs associated with atrial fibrillation (AFib), the most common form of cardiac arrhythmia. Each study evaluates these costs and updates a growing body of evidence suggesting that the true costs of AFib are complex and may not yet be fully understood. The patient populations studied mimic those in the landmark ATHENA trial, a placebo-controlled, double-blind, parallel arm trial to assess the safety and efficacy of dronedarone 400 mg bid for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.

Dronedarone is an antiarrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AFib) or atrial flutter (AFL), with a recent episode of AFib/AFL and associated cardiovascular risk factors (i.e., age >70, hypertension, diabetes, prior cerebrovascular accident, left atrial diameter ≥50 mm or left ventricular ejection fraction [LVEF] <40%), who are in sinus rhythm or who will be cardioverted.

Editorial support for development of this poster was funded by sanofi-aventis U.S. Inc.

Lead investigator, Alpesh N. Amin, MD, University of California, Irvine, is available to discuss key findings following each session.

WHERE: HeartRhythm 2011
San Francisco, CA or via Teleconference

WHEN: Thursday, May 5th, 9:00 AM PT
"Cost Burden to U.S. Payors of ATHENA-Like Patients with Atrial Fibrillation/Atrial Flutter" (poster presentation 11-A-5161-HRS)

Thursday, May 5th, 2:00 PM PT
"Rehospitalization Rates and Costs in Hospitalized ATHENA-Like U.S. Patients with Atrial Fibrillation/Atrial Flutter" (oral presentation 11-A-5148-HRS)

Atrial Fibrillation is the most common form of cardiac arrhythmia. It is associated with an increased risk for stroke , heart failure and death and its prevalence is expected to rise as the population ages In fact, as a growing population of Americans begins to reach their Medicare years, AFib which disproportionately affects those over the age of 65 has the potential to be a largely unrecognized cost-driver.


'/>"/>

Contact: Tom Murphy
tmurphy@ccapr.com
202-609-6005
Chandler Chicco Agency
Source:Eurekalert

Related medicine news :

1. Study evaluates costs and benefits of new chemotherapy drugs
2. Study evaluates costs and benefits associated with new colon cancer therapies
3. Study evaluates importance of timeliness of care in breast cancer diagnosis and treatment
4. Burden of HIV/TB infections increasingly falling on Hispanic community
5. Late-stage melanoma results in economic burden
6. NJHA: Charity Care Must Be a Priority as Uninsured Burden Grows
7. Inequities exists in disease burden, health care and access for minority children
8. For Migraine Sufferers, Stigma Adds to Burden
9. International liver cancer congress provides possible solutions to reduce significant burden
10. Kroll Fraud Solutions' New HITECH Hotline Eases Burden of Data Breach Notification for Healthcare
11. Insurance Woes Can Add to Burden of Psoriasis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that ... the risk of visual loss in these patients. , But how often do ophthalmologists ... smoking cessation to patients at risk of or with early symptoms of AMD? A ...
(Date:6/23/2017)... ... , ... Military Connection friend and veteran advocate Micaela Bensko and ... lounge. , Bensko is no stranger to the plight of the disabled. Before ... to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds of ...
(Date:6/23/2017)... , ... June 23, 2017 , ... The Aesthetic Channel ... . Dr. Talei has come up with a proprietary technique that he calls the ... tissues that have dropped. For all ages, patients can expect to look refreshed, rejuvenated, ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South ... selected 21 leaders from government, business and civil society in 11 countries across the ... this fall, engaging in a transformative exchange of knowledge and ideas with the leading ...
(Date:6/23/2017)... ... 2017 , ... Ross Insurance Agency ( http://www.rossinsuranceagency.com ) saves ... Agency’s (FEMA) recent update of flood zones, more people than ever are in ... enacted to reflect the actual risk in flood zone areas during a time ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/13/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... Food and Drug Administration (FDA) has notified the Company that ... Zhejiang, China manufacturing facility has been ... clearance of the Warning Letter related to our ... of the progress we have made in our ongoing quality ...
(Date:6/10/2017)... 9, 2017  Shane K. Burchfield, DPM, is recognized by Continental ... a Podiatrist in Alabama . ... Foot Care. He brings over 20 years of experience, as well ... healthcare, to his role. ... is pleased to welcome you to his practice," the ...
Breaking Medicine Technology: